Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

If you knew that the blueberry muffin you had this morning contained 438 calories, would you have thought twice before choosing it to go with your coffee? If calories had been shown on the menu might it have influenced the pizza or pasta you selected for dinner last night?

When Michael Bloomberg was mayor of New York City, he led the way with policies to enforce calorie labelling on menus. Many states followed suit, and this year the labelling will finally become mandatory across the USA for chains with more than 20 outlets. In the UK, around 70% of high street coffee shops, quick-serve restaurants and other chains now label the calorie content of their products too, albeit on a voluntary basis.

It’s easy to support nutritional labelling as a consumer right, to allow people who want this information to make informed choices about what they eat. But it’s been less clear whether labelling actually leads to a reduction in the calories we eat.

Read the full article on The Conversation website, written by Susan Jebb, Nuffield Department of Primary Care Health Sciences, and Theresa Marteau, Director of the Behaviour and Health Research Unit at the University of Cambridge. 

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.

Researchers set out steps to address mental health effects of the pandemic on young people

Researchers have outlined 14 steps that schools, mental health services and policymakers can take to help children and young people whose mental health has been affected by the COVID-19 pandemic.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.

Professor Trish Greenhalgh Highly Commended in the O²RB Excellence in Impact Awards 2021

Congratulations to Professor Trish Greenhalgh (Nuffield Department of Primary Care Health Sciences) who has been Highly Commended in the O²RB Excellence in Impact Awards 2021.

No benefit of convalescent plasma for critically ill COVID-19 patients

A large study of over 2000 COVID-19 patients has found that giving critically ill patients blood plasma from recovered COVID-19 patients did not significantly reduce deaths, or the need for intensive care support such as being put on a ventilator machine.